Seigou Akao

801 citations
9 papers · 598 indexed · h-index 7

Seigou Akao

9 papers receiving 551 citations

Peers

Seigou Akao
Comparison fields: 5 of 86
  • Applied Microbiology and Biotechnology 110
  • Pharmacology 128
  • Pharmacology 220
  • Biochemistry 70
  • Molecular Medicine 37
Replace Shian‐Ren Lin with:
Shian‐Ren Lin Taiwan
Chun Shu Yu Taiwan
Riris Istighfari Jenie Indonesia
Andrew Hitron United States
Chia-Yu Ma Taiwan
Yi-Shih Ma Taiwan
Ching-Lung Liao Taiwan
Hala U. Gali United States
Keiko Sakata Japan
Julia Kin-Ming Lee Hong Kong
Seigou Akao relative to Shian‐Ren Lin Taiwan Shian‐Ren Lin's profile →
Citations per field
00.5×
Shian‐Ren Lin · 1×
Citations per year

Countries citing papers authored by Seigou Akao

Since Specialization
Citations

This map shows the geographic impact of Seigou Akao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Seigou Akao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Seigou Akao more than expected).

Fields of papers citing papers by Seigou Akao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Seigou Akao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Seigou Akao. The network helps show where Seigou Akao may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Seigou Akao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Seigou Akao Line = papers co-authored together Seigou Akao links everyone, so they are left out of the graph.

All Works

9 of 9 papers shown
#Work
1
Multi-Center Randomized Controlled Trial of Acupuncture and Moxibustion for Rheumatoid Arthritis
20051
2 20052
3 200135
4 2001149
5 200032
6 200023
7 1999232
8 199999
9
Isolation and characterization of proteoglycans from human nonepithelial tumors.
198725

About Seigou Akao

Seigou Akao is a scholar working on Applied Microbiology and Biotechnology, Complementary and Manual Therapy and Complementary and alternative medicine, having authored 9 papers that have together received 598 indexed citations. Recurring topics across this work include Tannin, Tannase and Anticancer Activities (3 papers), Metal complexes synthesis and properties (2 papers), Plant Toxicity and Pharmacological Properties (2 papers), Acupuncture Treatment Research Studies (2 papers), Sesquiterpenes and Asteraceae Studies (2 papers), Natural product bioactivities and synthesis (2 papers), Berberine and alkaloids research (1 paper) and Traditional Chinese Medicine Studies (1 paper). The work is most often cited by research in Applied Microbiology and Biotechnology (110 citations), Pharmacology (128 citations) and Pharmacology (220 citations). Seigou Akao has collaborated with scholars based in Japan. Frequent co-authors include Hisayoshi Fujiwara, Kazunori Fukuda, Yuko Hibiya, Michihiro Mutoh, Masatoshi Koshiji, Yasushi Ohno, Genzou Takemura, Norio Yasuda, Motohiro WATANABE and Shinya Minatoguchi. Their work appears in journals such as Biochemical Pharmacology, Journal of Ethnopharmacology and Cancer Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026